Search

everythinglearnresearchcommunity

for

Search:↓

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Fusarium sp. strain K-23 helps Arabidopsis plants grow better in salty soil by promoting root hair growth.

Jasmonic acid helps plants grow, defend against threats, and survive stressful conditions like drought and salt.

The conclusion suggests that a new system for measuring hair loss could be created using automated analysis of photographs.

MR antagonists may improve skin health and wound healing, especially in aging.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Higher levels of PD-L1 are linked to more severe hair loss in people with Alopecia Areata.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

Low vitamin D might be one of several factors involved in the hair loss condition alopecia areata.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

There are two main types of alopecia areata with different severity, and diagnosis is made through clinical examination and trichoscopy, influencing treatment choices.

Keratin from hair binds well to gold and BMP-2, useful for bone repair.

Low vitamin D levels are common in people with Alopecia Areata.

A woman's hair grew back with baricitinib treatment, but she developed a temporary hairy tongue that was treated with regular tongue brushing.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

Hair straightening methods have advanced to improve effectiveness and reduce damage, but still rely on heat and chemicals.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Researchers created a fast, accurate computer program to measure hair loss in alopecia areata patients.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.